Global Primary Biliary Cirrhosis Drug Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Primary Biliary Cirrhosis Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Primary Biliary Cirrhosis Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Primary Biliary Cirrhosis Drug market in any manner.
Global Primary Biliary Cirrhosis Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AlbireoPharma
CymaBay Therapeutics, Inc.
Dr. Falk Pharma GmbH
Enanta Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Intercept Pharmaceuticals, Inc.
Johnson & Johnson
MediGene AG
NGM Biopharmaceuticals, Inc.
Virobay Inc.
Market Segmentation (by Type)
Budesonide
FFP-104
GSK-2330672
MBX-8025
NGM-282
Others
Market Segmentation (by Application)
Clinic
Hospital
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Primary Biliary Cirrhosis Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Primary Biliary Cirrhosis Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Primary Biliary Cirrhosis Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Primary Biliary Cirrhosis Drug market in any manner.
Global Primary Biliary Cirrhosis Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AlbireoPharma
CymaBay Therapeutics, Inc.
Dr. Falk Pharma GmbH
Enanta Pharmaceuticals, Inc.
GlaxoSmithKline Plc
Intercept Pharmaceuticals, Inc.
Johnson & Johnson
MediGene AG
NGM Biopharmaceuticals, Inc.
Virobay Inc.
Market Segmentation (by Type)
Budesonide
FFP-104
GSK-2330672
MBX-8025
NGM-282
Others
Market Segmentation (by Application)
Clinic
Hospital
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Primary Biliary Cirrhosis Drug Market
- Overview of the regional outlook of the Primary Biliary Cirrhosis Drug Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Primary Biliary Cirrhosis Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Primary Biliary Cirrhosis Drug
1.2 Key Market Segments
1.2.1 Primary Biliary Cirrhosis Drug Segment by Type
1.2.2 Primary Biliary Cirrhosis Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRIMARY BILIARY CIRRHOSIS DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Primary Biliary Cirrhosis Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Primary Biliary Cirrhosis Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRIMARY BILIARY CIRRHOSIS DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Primary Biliary Cirrhosis Drug Sales by Manufacturers (2019-2024)
3.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Primary Biliary Cirrhosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Primary Biliary Cirrhosis Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Primary Biliary Cirrhosis Drug Sales Sites, Area Served, Product Type
3.6 Primary Biliary Cirrhosis Drug Market Competitive Situation and Trends
3.6.1 Primary Biliary Cirrhosis Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Primary Biliary Cirrhosis Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PRIMARY BILIARY CIRRHOSIS DRUG INDUSTRY CHAIN ANALYSIS
4.1 Primary Biliary Cirrhosis Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRIMARY BILIARY CIRRHOSIS DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PRIMARY BILIARY CIRRHOSIS DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Primary Biliary Cirrhosis Drug Sales Market Share by Type (2019-2024)
6.3 Global Primary Biliary Cirrhosis Drug Market Size Market Share by Type (2019-2024)
6.4 Global Primary Biliary Cirrhosis Drug Price by Type (2019-2024)
7 PRIMARY BILIARY CIRRHOSIS DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Primary Biliary Cirrhosis Drug Market Sales by Application (2019-2024)
7.3 Global Primary Biliary Cirrhosis Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Primary Biliary Cirrhosis Drug Sales Growth Rate by Application (2019-2024)
8 PRIMARY BILIARY CIRRHOSIS DRUG MARKET SEGMENTATION BY REGION
8.1 Global Primary Biliary Cirrhosis Drug Sales by Region
8.1.1 Global Primary Biliary Cirrhosis Drug Sales by Region
8.1.2 Global Primary Biliary Cirrhosis Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Primary Biliary Cirrhosis Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Primary Biliary Cirrhosis Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Primary Biliary Cirrhosis Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Primary Biliary Cirrhosis Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Primary Biliary Cirrhosis Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AlbireoPharma
9.1.1 AlbireoPharma Primary Biliary Cirrhosis Drug Basic Information
9.1.2 AlbireoPharma Primary Biliary Cirrhosis Drug Product Overview
9.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Product Market Performance
9.1.4 AlbireoPharma Business Overview
9.1.5 AlbireoPharma Primary Biliary Cirrhosis Drug SWOT Analysis
9.1.6 AlbireoPharma Recent Developments
9.2 CymaBay Therapeutics, Inc.
9.2.1 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Basic Information
9.2.2 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product Overview
9.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product Market Performance
9.2.4 CymaBay Therapeutics, Inc. Business Overview
9.2.5 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug SWOT Analysis
9.2.6 CymaBay Therapeutics, Inc. Recent Developments
9.3 Dr. Falk Pharma GmbH
9.3.1 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Basic Information
9.3.2 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product Overview
9.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product Market Performance
9.3.4 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug SWOT Analysis
9.3.5 Dr. Falk Pharma GmbH Business Overview
9.3.6 Dr. Falk Pharma GmbH Recent Developments
9.4 Enanta Pharmaceuticals, Inc.
9.4.1 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information
9.4.2 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Overview
9.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Market Performance
9.4.4 Enanta Pharmaceuticals, Inc. Business Overview
9.4.5 Enanta Pharmaceuticals, Inc. Recent Developments
9.5 GlaxoSmithKline Plc
9.5.1 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Basic Information
9.5.2 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product Overview
9.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product Market Performance
9.5.4 GlaxoSmithKline Plc Business Overview
9.5.5 GlaxoSmithKline Plc Recent Developments
9.6 Intercept Pharmaceuticals, Inc.
9.6.1 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information
9.6.2 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Overview
9.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Market Performance
9.6.4 Intercept Pharmaceuticals, Inc. Business Overview
9.6.5 Intercept Pharmaceuticals, Inc. Recent Developments
9.7 Johnson and Johnson
9.7.1 Johnson and Johnson Primary Biliary Cirrhosis Drug Basic Information
9.7.2 Johnson and Johnson Primary Biliary Cirrhosis Drug Product Overview
9.7.3 Johnson and Johnson Primary Biliary Cirrhosis Drug Product Market Performance
9.7.4 Johnson and Johnson Business Overview
9.7.5 Johnson and Johnson Recent Developments
9.8 MediGene AG
9.8.1 MediGene AG Primary Biliary Cirrhosis Drug Basic Information
9.8.2 MediGene AG Primary Biliary Cirrhosis Drug Product Overview
9.8.3 MediGene AG Primary Biliary Cirrhosis Drug Product Market Performance
9.8.4 MediGene AG Business Overview
9.8.5 MediGene AG Recent Developments
9.9 NGM Biopharmaceuticals, Inc.
9.9.1 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information
9.9.2 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Overview
9.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Market Performance
9.9.4 NGM Biopharmaceuticals, Inc. Business Overview
9.9.5 NGM Biopharmaceuticals, Inc. Recent Developments
9.10 Virobay Inc.
9.10.1 Virobay Inc. Primary Biliary Cirrhosis Drug Basic Information
9.10.2 Virobay Inc. Primary Biliary Cirrhosis Drug Product Overview
9.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Product Market Performance
9.10.4 Virobay Inc. Business Overview
9.10.5 Virobay Inc. Recent Developments
10 PRIMARY BILIARY CIRRHOSIS DRUG MARKET FORECAST BY REGION
10.1 Global Primary Biliary Cirrhosis Drug Market Size Forecast
10.2 Global Primary Biliary Cirrhosis Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Primary Biliary Cirrhosis Drug Market Size Forecast by Country
10.2.3 Asia Pacific Primary Biliary Cirrhosis Drug Market Size Forecast by Region
10.2.4 South America Primary Biliary Cirrhosis Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Primary Biliary Cirrhosis Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Primary Biliary Cirrhosis Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Primary Biliary Cirrhosis Drug by Type (2025-2030)
11.1.2 Global Primary Biliary Cirrhosis Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Primary Biliary Cirrhosis Drug by Type (2025-2030)
11.2 Global Primary Biliary Cirrhosis Drug Market Forecast by Application (2025-2030)
11.2.1 Global Primary Biliary Cirrhosis Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Primary Biliary Cirrhosis Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Primary Biliary Cirrhosis Drug
1.2 Key Market Segments
1.2.1 Primary Biliary Cirrhosis Drug Segment by Type
1.2.2 Primary Biliary Cirrhosis Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PRIMARY BILIARY CIRRHOSIS DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Primary Biliary Cirrhosis Drug Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Primary Biliary Cirrhosis Drug Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PRIMARY BILIARY CIRRHOSIS DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Global Primary Biliary Cirrhosis Drug Sales by Manufacturers (2019-2024)
3.2 Global Primary Biliary Cirrhosis Drug Revenue Market Share by Manufacturers (2019-2024)
3.3 Primary Biliary Cirrhosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Primary Biliary Cirrhosis Drug Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Primary Biliary Cirrhosis Drug Sales Sites, Area Served, Product Type
3.6 Primary Biliary Cirrhosis Drug Market Competitive Situation and Trends
3.6.1 Primary Biliary Cirrhosis Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Primary Biliary Cirrhosis Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PRIMARY BILIARY CIRRHOSIS DRUG INDUSTRY CHAIN ANALYSIS
4.1 Primary Biliary Cirrhosis Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PRIMARY BILIARY CIRRHOSIS DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PRIMARY BILIARY CIRRHOSIS DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Primary Biliary Cirrhosis Drug Sales Market Share by Type (2019-2024)
6.3 Global Primary Biliary Cirrhosis Drug Market Size Market Share by Type (2019-2024)
6.4 Global Primary Biliary Cirrhosis Drug Price by Type (2019-2024)
7 PRIMARY BILIARY CIRRHOSIS DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Primary Biliary Cirrhosis Drug Market Sales by Application (2019-2024)
7.3 Global Primary Biliary Cirrhosis Drug Market Size (M USD) by Application (2019-2024)
7.4 Global Primary Biliary Cirrhosis Drug Sales Growth Rate by Application (2019-2024)
8 PRIMARY BILIARY CIRRHOSIS DRUG MARKET SEGMENTATION BY REGION
8.1 Global Primary Biliary Cirrhosis Drug Sales by Region
8.1.1 Global Primary Biliary Cirrhosis Drug Sales by Region
8.1.2 Global Primary Biliary Cirrhosis Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Primary Biliary Cirrhosis Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Primary Biliary Cirrhosis Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Primary Biliary Cirrhosis Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Primary Biliary Cirrhosis Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Primary Biliary Cirrhosis Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AlbireoPharma
9.1.1 AlbireoPharma Primary Biliary Cirrhosis Drug Basic Information
9.1.2 AlbireoPharma Primary Biliary Cirrhosis Drug Product Overview
9.1.3 AlbireoPharma Primary Biliary Cirrhosis Drug Product Market Performance
9.1.4 AlbireoPharma Business Overview
9.1.5 AlbireoPharma Primary Biliary Cirrhosis Drug SWOT Analysis
9.1.6 AlbireoPharma Recent Developments
9.2 CymaBay Therapeutics, Inc.
9.2.1 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Basic Information
9.2.2 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product Overview
9.2.3 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product Market Performance
9.2.4 CymaBay Therapeutics, Inc. Business Overview
9.2.5 CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug SWOT Analysis
9.2.6 CymaBay Therapeutics, Inc. Recent Developments
9.3 Dr. Falk Pharma GmbH
9.3.1 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Basic Information
9.3.2 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product Overview
9.3.3 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product Market Performance
9.3.4 Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug SWOT Analysis
9.3.5 Dr. Falk Pharma GmbH Business Overview
9.3.6 Dr. Falk Pharma GmbH Recent Developments
9.4 Enanta Pharmaceuticals, Inc.
9.4.1 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information
9.4.2 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Overview
9.4.3 Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Market Performance
9.4.4 Enanta Pharmaceuticals, Inc. Business Overview
9.4.5 Enanta Pharmaceuticals, Inc. Recent Developments
9.5 GlaxoSmithKline Plc
9.5.1 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Basic Information
9.5.2 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product Overview
9.5.3 GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product Market Performance
9.5.4 GlaxoSmithKline Plc Business Overview
9.5.5 GlaxoSmithKline Plc Recent Developments
9.6 Intercept Pharmaceuticals, Inc.
9.6.1 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information
9.6.2 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Overview
9.6.3 Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Market Performance
9.6.4 Intercept Pharmaceuticals, Inc. Business Overview
9.6.5 Intercept Pharmaceuticals, Inc. Recent Developments
9.7 Johnson and Johnson
9.7.1 Johnson and Johnson Primary Biliary Cirrhosis Drug Basic Information
9.7.2 Johnson and Johnson Primary Biliary Cirrhosis Drug Product Overview
9.7.3 Johnson and Johnson Primary Biliary Cirrhosis Drug Product Market Performance
9.7.4 Johnson and Johnson Business Overview
9.7.5 Johnson and Johnson Recent Developments
9.8 MediGene AG
9.8.1 MediGene AG Primary Biliary Cirrhosis Drug Basic Information
9.8.2 MediGene AG Primary Biliary Cirrhosis Drug Product Overview
9.8.3 MediGene AG Primary Biliary Cirrhosis Drug Product Market Performance
9.8.4 MediGene AG Business Overview
9.8.5 MediGene AG Recent Developments
9.9 NGM Biopharmaceuticals, Inc.
9.9.1 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information
9.9.2 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Overview
9.9.3 NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Market Performance
9.9.4 NGM Biopharmaceuticals, Inc. Business Overview
9.9.5 NGM Biopharmaceuticals, Inc. Recent Developments
9.10 Virobay Inc.
9.10.1 Virobay Inc. Primary Biliary Cirrhosis Drug Basic Information
9.10.2 Virobay Inc. Primary Biliary Cirrhosis Drug Product Overview
9.10.3 Virobay Inc. Primary Biliary Cirrhosis Drug Product Market Performance
9.10.4 Virobay Inc. Business Overview
9.10.5 Virobay Inc. Recent Developments
10 PRIMARY BILIARY CIRRHOSIS DRUG MARKET FORECAST BY REGION
10.1 Global Primary Biliary Cirrhosis Drug Market Size Forecast
10.2 Global Primary Biliary Cirrhosis Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Primary Biliary Cirrhosis Drug Market Size Forecast by Country
10.2.3 Asia Pacific Primary Biliary Cirrhosis Drug Market Size Forecast by Region
10.2.4 South America Primary Biliary Cirrhosis Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Primary Biliary Cirrhosis Drug by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Primary Biliary Cirrhosis Drug Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Primary Biliary Cirrhosis Drug by Type (2025-2030)
11.1.2 Global Primary Biliary Cirrhosis Drug Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Primary Biliary Cirrhosis Drug by Type (2025-2030)
11.2 Global Primary Biliary Cirrhosis Drug Market Forecast by Application (2025-2030)
11.2.1 Global Primary Biliary Cirrhosis Drug Sales (Kilotons) Forecast by Application
11.2.2 Global Primary Biliary Cirrhosis Drug Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Primary Biliary Cirrhosis Drug Market Size Comparison by Region (M USD)
Table 5. Global Primary Biliary Cirrhosis Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Primary Biliary Cirrhosis Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Primary Biliary Cirrhosis Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Primary Biliary Cirrhosis Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Biliary Cirrhosis Drug as of 2022)
Table 10. Global Market Primary Biliary Cirrhosis Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Primary Biliary Cirrhosis Drug Sales Sites and Area Served
Table 12. Manufacturers Primary Biliary Cirrhosis Drug Product Type
Table 13. Global Primary Biliary Cirrhosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Primary Biliary Cirrhosis Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Primary Biliary Cirrhosis Drug Market Challenges
Table 22. Global Primary Biliary Cirrhosis Drug Sales by Type (Kilotons)
Table 23. Global Primary Biliary Cirrhosis Drug Market Size by Type (M USD)
Table 24. Global Primary Biliary Cirrhosis Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Primary Biliary Cirrhosis Drug Sales Market Share by Type (2019-2024)
Table 26. Global Primary Biliary Cirrhosis Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Primary Biliary Cirrhosis Drug Market Size Share by Type (2019-2024)
Table 28. Global Primary Biliary Cirrhosis Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Primary Biliary Cirrhosis Drug Sales (Kilotons) by Application
Table 30. Global Primary Biliary Cirrhosis Drug Market Size by Application
Table 31. Global Primary Biliary Cirrhosis Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Primary Biliary Cirrhosis Drug Sales Market Share by Application (2019-2024)
Table 33. Global Primary Biliary Cirrhosis Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Primary Biliary Cirrhosis Drug Market Share by Application (2019-2024)
Table 35. Global Primary Biliary Cirrhosis Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Primary Biliary Cirrhosis Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Primary Biliary Cirrhosis Drug Sales Market Share by Region (2019-2024)
Table 38. North America Primary Biliary Cirrhosis Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Primary Biliary Cirrhosis Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Primary Biliary Cirrhosis Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Primary Biliary Cirrhosis Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Primary Biliary Cirrhosis Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. AlbireoPharma Primary Biliary Cirrhosis Drug Basic Information
Table 44. AlbireoPharma Primary Biliary Cirrhosis Drug Product Overview
Table 45. AlbireoPharma Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. AlbireoPharma Business Overview
Table 47. AlbireoPharma Primary Biliary Cirrhosis Drug SWOT Analysis
Table 48. AlbireoPharma Recent Developments
Table 49. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Basic Information
Table 50. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product Overview
Table 51. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CymaBay Therapeutics, Inc. Business Overview
Table 53. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug SWOT Analysis
Table 54. CymaBay Therapeutics, Inc. Recent Developments
Table 55. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Basic Information
Table 56. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product Overview
Table 57. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug SWOT Analysis
Table 59. Dr. Falk Pharma GmbH Business Overview
Table 60. Dr. Falk Pharma GmbH Recent Developments
Table 61. Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information
Table 62. Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Overview
Table 63. Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Enanta Pharmaceuticals, Inc. Business Overview
Table 65. Enanta Pharmaceuticals, Inc. Recent Developments
Table 66. GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Basic Information
Table 67. GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product Overview
Table 68. GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Plc Business Overview
Table 70. GlaxoSmithKline Plc Recent Developments
Table 71. Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information
Table 72. Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Overview
Table 73. Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Intercept Pharmaceuticals, Inc. Business Overview
Table 75. Intercept Pharmaceuticals, Inc. Recent Developments
Table 76. Johnson and Johnson Primary Biliary Cirrhosis Drug Basic Information
Table 77. Johnson and Johnson Primary Biliary Cirrhosis Drug Product Overview
Table 78. Johnson and Johnson Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Johnson and Johnson Business Overview
Table 80. Johnson and Johnson Recent Developments
Table 81. MediGene AG Primary Biliary Cirrhosis Drug Basic Information
Table 82. MediGene AG Primary Biliary Cirrhosis Drug Product Overview
Table 83. MediGene AG Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. MediGene AG Business Overview
Table 85. MediGene AG Recent Developments
Table 86. NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information
Table 87. NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Overview
Table 88. NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. NGM Biopharmaceuticals, Inc. Business Overview
Table 90. NGM Biopharmaceuticals, Inc. Recent Developments
Table 91. Virobay Inc. Primary Biliary Cirrhosis Drug Basic Information
Table 92. Virobay Inc. Primary Biliary Cirrhosis Drug Product Overview
Table 93. Virobay Inc. Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Virobay Inc. Business Overview
Table 95. Virobay Inc. Recent Developments
Table 96. Global Primary Biliary Cirrhosis Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Primary Biliary Cirrhosis Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Primary Biliary Cirrhosis Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Primary Biliary Cirrhosis Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Primary Biliary Cirrhosis Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Primary Biliary Cirrhosis Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Primary Biliary Cirrhosis Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Primary Biliary Cirrhosis Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Primary Biliary Cirrhosis Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Primary Biliary Cirrhosis Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Primary Biliary Cirrhosis Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Primary Biliary Cirrhosis Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Primary Biliary Cirrhosis Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Primary Biliary Cirrhosis Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Primary Biliary Cirrhosis Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Primary Biliary Cirrhosis Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Primary Biliary Cirrhosis Drug Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Primary Biliary Cirrhosis Drug Market Size Comparison by Region (M USD)
Table 5. Global Primary Biliary Cirrhosis Drug Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Primary Biliary Cirrhosis Drug Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Primary Biliary Cirrhosis Drug Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Primary Biliary Cirrhosis Drug Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Primary Biliary Cirrhosis Drug as of 2022)
Table 10. Global Market Primary Biliary Cirrhosis Drug Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Primary Biliary Cirrhosis Drug Sales Sites and Area Served
Table 12. Manufacturers Primary Biliary Cirrhosis Drug Product Type
Table 13. Global Primary Biliary Cirrhosis Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Primary Biliary Cirrhosis Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Primary Biliary Cirrhosis Drug Market Challenges
Table 22. Global Primary Biliary Cirrhosis Drug Sales by Type (Kilotons)
Table 23. Global Primary Biliary Cirrhosis Drug Market Size by Type (M USD)
Table 24. Global Primary Biliary Cirrhosis Drug Sales (Kilotons) by Type (2019-2024)
Table 25. Global Primary Biliary Cirrhosis Drug Sales Market Share by Type (2019-2024)
Table 26. Global Primary Biliary Cirrhosis Drug Market Size (M USD) by Type (2019-2024)
Table 27. Global Primary Biliary Cirrhosis Drug Market Size Share by Type (2019-2024)
Table 28. Global Primary Biliary Cirrhosis Drug Price (USD/Ton) by Type (2019-2024)
Table 29. Global Primary Biliary Cirrhosis Drug Sales (Kilotons) by Application
Table 30. Global Primary Biliary Cirrhosis Drug Market Size by Application
Table 31. Global Primary Biliary Cirrhosis Drug Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Primary Biliary Cirrhosis Drug Sales Market Share by Application (2019-2024)
Table 33. Global Primary Biliary Cirrhosis Drug Sales by Application (2019-2024) & (M USD)
Table 34. Global Primary Biliary Cirrhosis Drug Market Share by Application (2019-2024)
Table 35. Global Primary Biliary Cirrhosis Drug Sales Growth Rate by Application (2019-2024)
Table 36. Global Primary Biliary Cirrhosis Drug Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Primary Biliary Cirrhosis Drug Sales Market Share by Region (2019-2024)
Table 38. North America Primary Biliary Cirrhosis Drug Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Primary Biliary Cirrhosis Drug Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Primary Biliary Cirrhosis Drug Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Primary Biliary Cirrhosis Drug Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Primary Biliary Cirrhosis Drug Sales by Region (2019-2024) & (Kilotons)
Table 43. AlbireoPharma Primary Biliary Cirrhosis Drug Basic Information
Table 44. AlbireoPharma Primary Biliary Cirrhosis Drug Product Overview
Table 45. AlbireoPharma Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. AlbireoPharma Business Overview
Table 47. AlbireoPharma Primary Biliary Cirrhosis Drug SWOT Analysis
Table 48. AlbireoPharma Recent Developments
Table 49. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Basic Information
Table 50. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Product Overview
Table 51. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. CymaBay Therapeutics, Inc. Business Overview
Table 53. CymaBay Therapeutics, Inc. Primary Biliary Cirrhosis Drug SWOT Analysis
Table 54. CymaBay Therapeutics, Inc. Recent Developments
Table 55. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Basic Information
Table 56. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Product Overview
Table 57. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Dr. Falk Pharma GmbH Primary Biliary Cirrhosis Drug SWOT Analysis
Table 59. Dr. Falk Pharma GmbH Business Overview
Table 60. Dr. Falk Pharma GmbH Recent Developments
Table 61. Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information
Table 62. Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Overview
Table 63. Enanta Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Enanta Pharmaceuticals, Inc. Business Overview
Table 65. Enanta Pharmaceuticals, Inc. Recent Developments
Table 66. GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Basic Information
Table 67. GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Product Overview
Table 68. GlaxoSmithKline Plc Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. GlaxoSmithKline Plc Business Overview
Table 70. GlaxoSmithKline Plc Recent Developments
Table 71. Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information
Table 72. Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Overview
Table 73. Intercept Pharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Intercept Pharmaceuticals, Inc. Business Overview
Table 75. Intercept Pharmaceuticals, Inc. Recent Developments
Table 76. Johnson and Johnson Primary Biliary Cirrhosis Drug Basic Information
Table 77. Johnson and Johnson Primary Biliary Cirrhosis Drug Product Overview
Table 78. Johnson and Johnson Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Johnson and Johnson Business Overview
Table 80. Johnson and Johnson Recent Developments
Table 81. MediGene AG Primary Biliary Cirrhosis Drug Basic Information
Table 82. MediGene AG Primary Biliary Cirrhosis Drug Product Overview
Table 83. MediGene AG Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. MediGene AG Business Overview
Table 85. MediGene AG Recent Developments
Table 86. NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Basic Information
Table 87. NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Product Overview
Table 88. NGM Biopharmaceuticals, Inc. Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. NGM Biopharmaceuticals, Inc. Business Overview
Table 90. NGM Biopharmaceuticals, Inc. Recent Developments
Table 91. Virobay Inc. Primary Biliary Cirrhosis Drug Basic Information
Table 92. Virobay Inc. Primary Biliary Cirrhosis Drug Product Overview
Table 93. Virobay Inc. Primary Biliary Cirrhosis Drug Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Virobay Inc. Business Overview
Table 95. Virobay Inc. Recent Developments
Table 96. Global Primary Biliary Cirrhosis Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 97. Global Primary Biliary Cirrhosis Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Primary Biliary Cirrhosis Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 99. North America Primary Biliary Cirrhosis Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Primary Biliary Cirrhosis Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 101. Europe Primary Biliary Cirrhosis Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Primary Biliary Cirrhosis Drug Sales Forecast by Region (2025-2030) & (Kilotons)
Table 103. Asia Pacific Primary Biliary Cirrhosis Drug Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Primary Biliary Cirrhosis Drug Sales Forecast by Country (2025-2030) & (Kilotons)
Table 105. South America Primary Biliary Cirrhosis Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Primary Biliary Cirrhosis Drug Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Primary Biliary Cirrhosis Drug Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Primary Biliary Cirrhosis Drug Sales Forecast by Type (2025-2030) & (Kilotons)
Table 109. Global Primary Biliary Cirrhosis Drug Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Primary Biliary Cirrhosis Drug Price Forecast by Type (2025-2030) & (USD/Ton)
Table 111. Global Primary Biliary Cirrhosis Drug Sales (Kilotons) Forecast by Application (2025-2030)
Table 112. Global Primary Biliary Cirrhosis Drug Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Primary Biliary Cirrhosis Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Primary Biliary Cirrhosis Drug Market Size (M USD), 2019-2030
Figure 5. Global Primary Biliary Cirrhosis Drug Market Size (M USD) (2019-2030)
Figure 6. Global Primary Biliary Cirrhosis Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Primary Biliary Cirrhosis Drug Market Size by Country (M USD)
Figure 11. Primary Biliary Cirrhosis Drug Sales Share by Manufacturers in 2023
Figure 12. Global Primary Biliary Cirrhosis Drug Revenue Share by Manufacturers in 2023
Figure 13. Primary Biliary Cirrhosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Primary Biliary Cirrhosis Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Primary Biliary Cirrhosis Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Primary Biliary Cirrhosis Drug Market Share by Type
Figure 18. Sales Market Share of Primary Biliary Cirrhosis Drug by Type (2019-2024)
Figure 19. Sales Market Share of Primary Biliary Cirrhosis Drug by Type in 2023
Figure 20. Market Size Share of Primary Biliary Cirrhosis Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Primary Biliary Cirrhosis Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Primary Biliary Cirrhosis Drug Market Share by Application
Figure 24. Global Primary Biliary Cirrhosis Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Primary Biliary Cirrhosis Drug Sales Market Share by Application in 2023
Figure 26. Global Primary Biliary Cirrhosis Drug Market Share by Application (2019-2024)
Figure 27. Global Primary Biliary Cirrhosis Drug Market Share by Application in 2023
Figure 28. Global Primary Biliary Cirrhosis Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Primary Biliary Cirrhosis Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Primary Biliary Cirrhosis Drug Sales Market Share by Country in 2023
Figure 32. U.S. Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Primary Biliary Cirrhosis Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Primary Biliary Cirrhosis Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Primary Biliary Cirrhosis Drug Sales Market Share by Country in 2023
Figure 37. Germany Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Primary Biliary Cirrhosis Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Primary Biliary Cirrhosis Drug Sales Market Share by Region in 2023
Figure 44. China Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Primary Biliary Cirrhosis Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Primary Biliary Cirrhosis Drug Sales Market Share by Country in 2023
Figure 51. Brazil Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Primary Biliary Cirrhosis Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Primary Biliary Cirrhosis Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Primary Biliary Cirrhosis Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Primary Biliary Cirrhosis Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Primary Biliary Cirrhosis Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Primary Biliary Cirrhosis Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Primary Biliary Cirrhosis Drug Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Primary Biliary Cirrhosis Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Primary Biliary Cirrhosis Drug Market Size (M USD), 2019-2030
Figure 5. Global Primary Biliary Cirrhosis Drug Market Size (M USD) (2019-2030)
Figure 6. Global Primary Biliary Cirrhosis Drug Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Primary Biliary Cirrhosis Drug Market Size by Country (M USD)
Figure 11. Primary Biliary Cirrhosis Drug Sales Share by Manufacturers in 2023
Figure 12. Global Primary Biliary Cirrhosis Drug Revenue Share by Manufacturers in 2023
Figure 13. Primary Biliary Cirrhosis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Primary Biliary Cirrhosis Drug Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Primary Biliary Cirrhosis Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Primary Biliary Cirrhosis Drug Market Share by Type
Figure 18. Sales Market Share of Primary Biliary Cirrhosis Drug by Type (2019-2024)
Figure 19. Sales Market Share of Primary Biliary Cirrhosis Drug by Type in 2023
Figure 20. Market Size Share of Primary Biliary Cirrhosis Drug by Type (2019-2024)
Figure 21. Market Size Market Share of Primary Biliary Cirrhosis Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Primary Biliary Cirrhosis Drug Market Share by Application
Figure 24. Global Primary Biliary Cirrhosis Drug Sales Market Share by Application (2019-2024)
Figure 25. Global Primary Biliary Cirrhosis Drug Sales Market Share by Application in 2023
Figure 26. Global Primary Biliary Cirrhosis Drug Market Share by Application (2019-2024)
Figure 27. Global Primary Biliary Cirrhosis Drug Market Share by Application in 2023
Figure 28. Global Primary Biliary Cirrhosis Drug Sales Growth Rate by Application (2019-2024)
Figure 29. Global Primary Biliary Cirrhosis Drug Sales Market Share by Region (2019-2024)
Figure 30. North America Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Primary Biliary Cirrhosis Drug Sales Market Share by Country in 2023
Figure 32. U.S. Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Primary Biliary Cirrhosis Drug Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Primary Biliary Cirrhosis Drug Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Primary Biliary Cirrhosis Drug Sales Market Share by Country in 2023
Figure 37. Germany Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Primary Biliary Cirrhosis Drug Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Primary Biliary Cirrhosis Drug Sales Market Share by Region in 2023
Figure 44. China Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Primary Biliary Cirrhosis Drug Sales and Growth Rate (Kilotons)
Figure 50. South America Primary Biliary Cirrhosis Drug Sales Market Share by Country in 2023
Figure 51. Brazil Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Primary Biliary Cirrhosis Drug Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Primary Biliary Cirrhosis Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Primary Biliary Cirrhosis Drug Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Primary Biliary Cirrhosis Drug Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Primary Biliary Cirrhosis Drug Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Primary Biliary Cirrhosis Drug Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Primary Biliary Cirrhosis Drug Market Share Forecast by Type (2025-2030)
Figure 65. Global Primary Biliary Cirrhosis Drug Sales Forecast by Application (2025-2030)
Figure 66. Global Primary Biliary Cirrhosis Drug Market Share Forecast by Application (2025-2030)
